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The mainstay of treating nonfunctioning-pancreatic neuroendocrine tumors(NF-
PNETs) is surgical resection. However, minimally invasive approaches to 
pancreatic resection for treating NF-PNETs are not widely accepted, and the long-
term oncological outcomes of such approaches remain unknown.
AIM 
To determine the short- and long-term outcomes of minimally invasive pancreatic 
resection conducted in patients with NF-PNETs.
METHODS 
Prospective databases from Severance Hospital were searched for 110 patients 
who underwent curative resection for NF-PNETs between January 2003 and 
August 2018.
RESULTS 
The proportion of minimally invasive surgery (MIS) procedures performed for 
NF-PNET increased to more than 75% after 2013. There was no significant 
difference in post-operative complications (P = 0.654), including pancreatic fistula 
(P = 0.890) and delayed gastric emptying (P = 0.652), between MIS and open 
approaches. No statistically significant difference was found in disease-free 
survival between the open approach group and the MIS group (median follow-up 
period, 28.1 mo; P = 0.428). In addition, the surgical approach (MIS vs open) was 
not found to be an independent prognostic factor in treating NF-PNET patients 
[Exp(β) = 1.062; P = 0.929].
CONCLUSION 
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Regardless of the type of surgery, a minimally invasive approach can be safe and 
feasible for select NF-PNET patients.
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Core Tip: The mainstay of treating nonfunctioning-pancreatic neuroendocrine tumors (NF-
PNETs) is surgical resection. However, minimally invasive approaches to pancreatic 
resection for treating NF-PNETs are not widely accepted and the long-term oncological 
outcomes of such approaches remain unknown. In this Long-term retrospective study with 
large numbers of subjects, there was no significant difference the short-term outcomes and 
recurrence rate of open resection and minimally invasive resection of NF-PNET.
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Pancreatic neuroendocrine tumors (PNETs) are rare neoplasms of the pancreas, which 
are produced by multipotent stem cells in the pancreatic ductal epithelium. PNETs 
comprise only 1%-2% of pancreatic neoplasms but their incidence is increasing[1]. 
Nonfunctioning (NF)-PNETs account for 15%-50% of PNETs, and their incidence may 
be increasing because of increased rates of incidental detection in imaging studies for 
other reasons[1].
The main method for treating PNETs is surgical resection. The resection of primary 
tumors in patients with PNETs is associated with improved survival across all disease 
stages[2,3]. Low-risk PNETs in the pancreas body and tail are ideally treated with 
minimally invasive surgery (MIS), which should be tailored to the individual 
patient[4]. Some studies have shown that laparoscopic distal pancreatectomy of NF-
PNETs has comparable post-operative complications and oncological outcomes to an 
open approach[5-7]. However, minimally invasive approaches to pancreaticoduo-
denectomies and other types of surgery for treating NF-PNETs are not widely 
accepted, and the long-term oncological outcomes of such approaches remain 
unknown.
The objective of this study was to determine the short- and long-term outcomes of 
minimally invasive pancreatic resection performed in patients with NF-PNETs.
MATERIALS AND METHODS
Data collection
Prospective databases from Severance Hospital (Seoul, South Korea) were searched for 
patients who underwent curative resection for NF-PNETs between January 2003 and 
August 2018. Patients who underwent pancreatectomy in combination with resection 
were excluded. The Institutional Review Board approved this study (No. 4-2019-1136). 
Patients’ demographic, clinicopathologic and perioperative data were collected in an 
electronic medical record format and retrospectively reviewed. Patients who 
underwent distal pancreatectomy were defined as the distal-locating NF-PNET group; 
patients who underwent pylorus-preserving pancreaticoduodenectomy, central 
pancreatectomy, or total pancreatectomy for tumors located in the proximal part of the 
pancreas were defined as the proximal-locating NF-PNET group.
All surgeries were performed by specialized pancreatic surgeons. The decision of 
whether to conduct MIS or open surgery was mostly determined by tumor factors and 
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surgeon’s preference. R0 resection was characterized as a minimum margin length > 1 
mm. When there was no direct margin involvement by the tumor or such involvement 
was < 1 mm from the resection margin, such resections were classified as R1. 
Incomplete resection of all gross residual tumor structures was defined as an R2 
resection[8]. Tumor location was classified by the center of the tumor. Tumor grade was 
evaluated according to World Health Organization (WHO) classifications, using data 
from final pathological reports[9]. Post-operative complications were classied using 
the Clavien-Dindo classication system[10]. Post-operative pancreatic stulae were 
dened according to the definition created by the International Study Group of 
Pancreatic Fistula (commonly known as the ISGPF)[11]. Delayed gastric emptying was 
also defined according to the definition by the International Study Group of Pancreatic 
Surgery[12]. Disease recurrence was defined as suspicious image findings during post-
operative surveillance. The duration of disease-free survival (DFS) was calculated from 
the date of surgery to the date of recurrence.
Statistical analysis
SPSS (version 22.0; IBM Corp., Armonk, NY, United States) and R 3.3.3 software was 
used to conduct statistical analyses. Numerical variables are presented as medians 
with interquartile ranges, and the group results were compared with the Student’s t-
test or Mann-Whitney U test. Nominal variables are expressed as values and 
percentages and compared with the results of the chi-squared or Fisher’s exact test. 
Recurrence probabilities were estimated using Kaplan-Meier methodology and 
compared by log-rank analysis. Potential risk factors associated with tumor recurrence 
were analyzed using univariate and multivariate cox hazard regression models. To 
evaluate the correlation of tumor recurrence with MIS and open approaches, variables 
that were found to be associated with overall survival on univariate cox analysis and 
MIS were included in a multivariate cox proportional model. In all analyses, a two-
tailed P value less than 0.05 was considered to be statistically significant.
RESULTS
General patient characteristics
Between January 2003 and August 2018, a total of 110 patients underwent curative 
resection for NF-PNETs. Forty-eight patients (43.6%) underwent open curative 
resection, sixty-two (56.4%) minimally invasive curative resection, forty-seven 
laparoscopic curative resection (42.7%), and fifteen robot-assisted (13.6%) curative 
resection. Over the 15-year analysis period, the proportion of minimally invasive 
approaches increased to approximately 75% after 2013 (before 2007: 0%; 2007-2009: 
16.7%; 2010-2012: 31.8%; 2013-2015: 77.5%; 2016-2018: 76.7%, P = 0.001, Figure 1).
The median age of the 110 patients who underwent curative resection for NF-PNETs 
was 56.0 years (range: 46.0-63.0 years), with more female patients than male patients (n 
= 59, 53.6%). Fifty-one (46.4%) patients underwent distal pancreatectomy, twenty-two 
(20.0%) enucleation, seven (6.4%) central pancreatectomy, twenty-one (19.1%) pylorus-
preserving pancreaticoduodenectomy, and nine (8.2%) total pancreatectomy. The 
median tumor size was 1.8 cm (range: 1.2-3.2 cm). Approximately three-quarters of 
patients (n = 78, 70.9%) were grade 1 according to the 2010 WHO classification, 27 
(24.54%) were grade 2, and 4 (3.63%) were grade 3. One patient (0.9%) who underwent 
open central pancreatectomy in 1993 could not be defined according to the 2010 WHO 
classification, due to the lack of mitotic counts and other information in the final 
pathological reports. After surgery, approximately 50% of patients experienced 
complications, of whom 9 (8.1%) experienced severe complications, defined as 
Clavien-Dindo grades III–IV. The median length of patient stay in the hospital was 
11.5 d (range: 8.0-17.0 d). The clinicopathological characteristics and surgical details of 
NF-PNET patients are given in Table 1.
Comparative analysis of open and minimally invasive approaches in terms of distal 
locations of NF-PNETs
A comparison of the clinicopathological characteristics and surgical details of distal 
pancreatectomy are given in Table 2. Overall, there were no significantly different 
perioperative clinical parameters between the open distal pancreatectomy group and 
the minimally invasive distal pancreatectomy group (P > 0.05). Complication rates also 
did not differ significantly between groups (P = 0.729). In addition, the occurrence of 
post-operative pancreatic fistulae also did not differ significantly between groups. 
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Table 1 Clinicopathological characteristics of resected nonfunctioning pancreatic neuroendocrine tumors
Variable Finding
Age in yr, median (range) 56.0 (46.0–63.0)
Male, n (%) 51 (46.4)
BMI in kg/m², median (range) 24.1 (22.1–26.3)




Diabetes, preoperative, n (%) 20 (18.2)





Type of surgery, n (%)
Distal pancreatectomy 51 (46.4)
Enucleation 22 (20.0)
Central pancreatectomy 7 (6.4)
Pylorus-preservingpancreaticoduodenectomy 21 (19.1)
Total pancreatectomy 9 (8.2)
MIS or open, n (%)
MIS 62 (56.4)
Open 48 (43.6)
Post-operative length of stay in d, median (range) 11.5 (8.0–17.0)
Clavien-Dindo grade, n (%)








Grade A 47 (40.9%)
Grade B 6 (5.2%)
Grade C 0 (0%)
DGE by ISGPS
Grade A 18 (15.7%)
Grade B 1 (0.9%)
Grade C 0 (0%)
Resection margin status, n (%)
R0 97 (88.2)
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R1 5 (4.5)
R2 8 (7.3)
Pathological tumor size in cm, median (range) 1.8 (1.2–3.2)








No lymphadenectomy 44 (40.0%)
Metastasis present, n (%) 5 (4.5)





ASA: American Society of Anesthesiologists; BMI: Body mass index; DGE: Delayed gastric emptying; ENETS: European Neuroendocrine Tumor Society; 
ISGPS: International Study Group on Pancreatic Surgery; ISGPF: International Study Group on Pancreatic Fistula; POPF: Post-operative pancreatic stulae; 
WHO: World Health Organization.
However, the minimally invasive distal pancreatectomy group tended to have a 
shorter average post-operative length of stay (8.0 d) than the open distal 
pancreatectomy group (14.0 d, P < 0.001). There were no significantly difference in the 
number of lymph node sampling between the open group and the minimally invasive 
group (P = 0.767).
Comparative analysis of open and minimally invasive approaches in terms of 
proximal locations of NF-PNETs
Of the 110 patients, 37 were in the proximal location NF-PNET group, and 21 
underwent pylorus-preserving pancreaticoduodenectomy (57%), 7 (19%) central 
pancreatectomy, and 9 (27%) total pancreatectomy because the tumor was located on 
the proximal part or involved the whole pancreas.
In the comparative analysis, there was no significant difference in the average rates 
of post-operative complications, including post-operative pancreatic fistulae and 
delayed gastric emptying, between the open and MIS groups (Table 3). The average 
length of post-operative stay did not significantly differ between the open group (20.0 
d) and the MIS group (13.0 d) (P = 0.210). However, the average body mass index 
(referred to as BMI) of the open group (24.6) was significantly higher than that of the 
MIS group (21.9) (P = 0.006). The MIS group had a longer average operation time (512 
min) than the open group (346 min) (P < 0.001). The average pathological tumor size 
(1.5 cm) was significantly smaller in the MIS group than in the open group (2.6 cm, P = 
0.041). There were no significantly difference in the number of lymph node sampling 
between the open group and the minimally invasive group (P = 0.804).
Long-term oncological outcomes of NF-PNET resections
After a median follow-up period of 28.1 mo (range: 11.3–53.0 mo), 12 patients (10.9%) 
experienced recurrence (Open: 16.7%, MIS: 6.5%). Comparative analysis showed that 
there was no statistically significant difference in DFS rates between the open group 
and the MIS group (P = 0.428, Figure 2). In a subgroup analysis of distal location of 
NF-PNETs, with a median follow-up period of 22.1 mo (range: 10.7-41.3), 7 (13.7%) of 
the 51 patients who underwent distal pancreatectomy experienced recurrence (Open: 
25%, MIS: 10.3%). There was no significant difference in DFS rates between the open 
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Table 2 Clinicopathological characteristics of minimally invasive and open approaches in terms of the distal location of nonfunctioning 
pancreatic neuroendocrine tumors
Variable Open approach, n = 12 MIS, n = 39 P value
Male 7 (58.3%) 19 (48.7%) 0.801
Age in yr, median (range) 58.5 (51.0-64.5) 56.0 (47.0-64.5) 0.617
BMI in kg/m², median (range) 24.6 (22.1-25.5) 24.8 (22.9-27.3) 0.418
ASA grade, n (%) 0.243
I 5 (41.7) 7 (17.9)
II 5 (41.7) 23 (59.0)
Ш 2 (16.7) 9 (23.1)
Spleen-preserving distal pancreatectomy 5 (41.7%) 26 (66.6%)
Conversion, n (%) - 4 (10.2)
Robot-assisted - 8 (20.5%)
Operative time as minimum, median (range) 179.0 (159.5–251.5) 216.0 (185.5–276.0) 0.105
Blood loss in cc, median (range) 175.0 (65.0–450.0) 100 (45.0–275.0) 0.093
Clavien-Dindo grade 0.729
0: no complications 7 (58.3%) 26 (66.7%)
I 4 (33.3%) 10 (25.6%)
II 1 (8.3%) 2 (5.1%)
IIIa 0 (0.0%) 1 (2.6%)
DGE by ISGPS 0.561
Grade A 0 (0.0%) 4 (10.3%)
Grade B 0 (0.0%) 0 (0.0%)
Grade C 0 (0.0%) 0 (0.0%)
POPF by ISGPF 0.805
Grade A 7 (58.3%) 20 (51.3%)
Grade B 0 (0.0%) 1 (2.6%)
Grade C 0 (0.0%) 0 (0.0%)
Post-operative length of stay in d, median 
(range)
14.0 (11.5-16.0) 8.0 (7.0-10.5) < 0.001
Resection margin status 0.612
R0 12 (100.0%) 36 (92.3%)
R1 0 (0.0%) 2 (5.1%)
R2 0 (0.0%) 1 (2.6%)
Pathological tumor size in cm, median (range) 2.5 (1.4-3.9) 2.0 (1.5-3.2) 0.548
T stage by ENETS classification 0.563
T1 5 (41.7%) 20 (51.3%)
T2 2 (16.7%) 9 (23.1%)
T3 5 (41.7%) 10 (25.6%)
N stage 0.056
Negative 9 (75.0%) 38 (97.4%)
Positive 3 (25.0%) 1 (2.6%)
M stage
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0 12 (100.0%) 39 (100.0%)
Nodal harvest, median (range) 0.0 (0.0-5.5) 1.0 (0.0-3.5) 0.767
2010 WHO grade 0.365
G1 7 (57.1%) 25 (64.1%)
G2 4 (42.9%) 14 (35.9%)
G3 1 (8.3%) 0 (0%)
ASA: American Society of Anesthesiologists; BMI: Body mass index; DGE: Delayed gastric emptying; ENETS: European Neuroendocrine Tumor Society; 
ISGPS: International Study Group on Pancreatic Surgery; ISGPF: International Study Group on Pancreatic Fistula; MIS: Minimally invasive surgery; POPF: 
Post-operative pancreatic stulae; WHO: World Health Organization.
and MIS groups (P = 0.418). In addition, with a median follow-up period of 31.8 mo 
(range: 10.0–41.3 mo), 5 (13.5%) of the 37 patients, who had proximally located NF-
PNETs, experienced recurrence. There were also no significant differences in terms of 
DFS rates between the Open and MIS groups for treatment of proximally located NF-
PNETs (P = 0.178).
Univariate analysis showed that tumor size > 2.5 cm [hazard ratio (HR): 22.21, 
95%CI: 2.86-172.69; P = 0.003], 2010 WHO classification of G3 (HR: 71.55, 95%CI: 6.43-
795.75; P = 0.001), and lympho-vascular invasion (HR: 8.77, 95%CI: 2.75-27.93; P < 
0.001) were associated with tumor recurrence. Multivariate analysis also showed that 
these factors were associated with tumor recurrence. However, surgical approach, 
namely either MIS or open, was not associated with tumor recurrence (Table 4, 
Figure 2).
DISCUSSION
The current study showed that there was no significant difference in the short- and 
long-term outcomes of open resection and MIS. The surgical approach was not found 
to be an independent prognostic factor in treating NF-NET patients.
Since Gumbs et al[13] (2008) reported that minimally invasive distal pancreatectomy 
had shorter surgical durations and lengths of hospital stay than open distal 
pancreatectomy and similar levels of post-operative complications and oncological 
outcomes, many centers that perform laparoscopic distal pancreatectomies on PNET 
patients have shown the feasibility of a laparoscopic approach and its relative safety 
compared to open resection[14-16]. Laparoscopic distal pancreatectomies have similar 
oncological outcomes and levels of post-operative complications as open distal 
pancreatectomies but shorter hospital stays[6,7,17]. The other study also showed that 
robotic assisted distal pancreatectomy and laparoscopic distal pancreatectomy were 
similar in post-operative complication and long term outcomes[18]. Some studies have 
also been conducted in functional-PNET and NF-PNET patients. The current study 
was conducted with NF-PNET patients only, but its results were similar to those on 
distal pancreatectomies.
Previous studies showed lymph node metastasis in pNET indicated poor 
prognosis[19,20]. However a study have suggested that routine conventional distal 
pancreatectomies with splenectomies to retrieve regional lymph nodes may be too 
extensive for NF-PNET patients with 2010 WHO classification grade 1[21]. In this study, 
there are no significant difference between MIS and open approach in nodal harvest. 
Thus, minimally invasive distal pancreatectomies are a feasible and safe method for 
treating NF-PNET patients.
Some studies have compared minimally invasive and open pancreatic resections to 
other types of pancreatic resections for PNETs. One study showed that a minimally 
invasive approach and parenchyma-sparing techniques for treating PNETs did not 
increase morbidity or reduce survival rates[22]. In addition, other studies showed that 
minimally invasive and parenchyma-sparing operations were associated with shorter 
hospital stays[23,24,25]. However, that study did not compare the minimally invasive 
approach and open resection but rather compared traditional pancreatic resection and 
minimally invasive approaches with parenchyma-sparing techniques (central 
pancreatectomy, enucleation). In this study, in proximal pancreatic resections, 
including central pancreatectomies, pancreaticoduodenectomies and total 
pancreatectomies, open and minimally invasive resections had similar levels of post-
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Table 3 Clinicopathological characteristics of the minimally invasive surgery and open groups in terms of the proximal location of 
nonfunctioning pancreatic neuroendocrine tumors
Variable Open, n = 22 MIS, n = 15 P value
Male 11 (50.0%) 5 (33.3%) 0.505
Age in yr, median (range) 53.5 (40.0–65.0) 53.0 (43.0–65.5) 0.631
BMI in kg/m², median (range) 24.6 (22.7–27.3) 21.9 (21.1–23.4) 0.006
ASA grade, n (%) 0.069
I 6 (27.3) 0 (0.0)
II 14 (63.6) 12 (80.0)
III 2 (9.1) 3 (20.0)
Type of surgery 0.541
Central pancreatectomy 3 (13.6%) 4 (26.7%)
PPPD 14 (63.6%) 7 (46.7%)
Total pancreatectomy 5 (22.7%) 4 (26.7%)
Operative time in min, median (range) 346.0 (295.0-400.0) 512.0 (462.5-530.0) < 0.001
Blood loss in cc, median (range) 450.0 (100.0-1020.0) 400. (175.0-450.0) 0.515
Clavien-Dindo grade 0.489
0: no complications 10 (45.5%) 4 (26.7%)
I 8 (36.4%) 5 (33.3%)
II 1 (4.5%) 3 (20.0%)
IIIa 1 (4.5%) 1 (6.7%)
IIIb 2 (9.1%) 1 (6.7%)
IV 0 (0.0%) 1 (6.7%)
DGEby ISGPS 0.457
Grade A 7 (31.8%) 5 (33.3%)
Grade B 0 (0.0%) 1 (6.7%)
Grade C 0 (0.0%) 0 (0.0%)
POPF by ISGPF 0.571
Grade A 5 (22.7%) 4 (26.7%)
Grade B 1 (4.5%) 2 (13.3%)
Grade C 0 (0.0%) 0 (0.0%)
Post-operative length of stay in d, median 
(range)
20.0 (14.0–30.0) 13.0 (10.5–24.5) 0.210
Resection margin status 0.505
R0 20 (90.9%) 15 (100.0%)
R1 0 (0.0%) 0 (0.0%)
R2 2 (9.1%) 0 (0.0%)
Pathological tumor size incm, median (range) 2.6 (1.5-4.5) 1.5 (1.3-2.2) 0.041
T stage by ENETs classification 0.081
T1 6 (27.3%) 8 (53.3%)
T2 5 (22.7%) 0 (0.0%)
T3 11 (50.0%) 7 (46.7%)
N stage 1.000
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0 20 (90.9%) 13 (86.7%)
1 2 (9.1%) 2 (13.3%)
M stage 1.000
0 19 (86.4%) 13 (86.7%)
1 3 (13.6%) 2 (13.3%)
Nodal harvest, median (range) 7.5 (5-12) 6.0 (2.5-12.5) 0.804
2010 WHO grade 0.848
G1 16 (72.7%) 10 (66.7%)
G2 3 (13.6%) 4 (26.7%)
G3 2 (9.1%) 1 (6.7%)
Unknown 1 (4.5%) 0 (0%)
ASA: American Society of Anesthesiologists; BMI: Body mass index; DGE: Delayed gastric emptying; ENETS: European Neuroendocrine Tumour Society; 
ISGPS: International Study Group on Pancreatic Surgery; ISGPF: International Study Group on Pancreatic Fistula; MIS: Minimally invasive surgery; POPF: 
Post-operative pancreatic stulae; PPPD: Pylorus-preserving pancreaticoduodenectomy; WHO: World Health Organization.
Table 4 Factors associated with tumor recurrence after curative resection of nonfunctioning pancreatic neuroendocrine tumors
Univariate analysis Multivariate analysis
Variable
HR 95%CI P value HR 95%CI P value
Age > 60 yr 0.40 0.09-1.83 0.239
Male 1.95 0.62-6.16 0.254
Minimally invasive surgery 0.61 0.18-2.09 0.432 1.062 0.28-4.03 0.929
Tumor size > 2.5 cm 22.21 2.86-172.69 0.003 16.21 1.99-128.8 0.009
Positive resection margin 1.52 0.33–6.99 0.589
Poor differentiation, G3 71.55 6.43-795.75 0.001 24.429 1.99-277.95 0.017
Positive lymph node 1.93 0.42–8.83 0.398
Lympho-vascular invasion 8.77 2.75-27.93 < 0.001 3.56 0.96-13.2 0.058
HR: Hazard ratio.
operative complications. There was no difference between the rates of post-operative 
pancreatic fistulae. PNET patients had high risks of forming post-operative pancreatic 
fistulae, because the pancreas is soft and its ducts have small diameters[26]. Large tumor 
size, poor differentiation, and lympho-vascular invasion are associated with NF-PNET 
tumor recurrence in this study and other study[27]. The diagnosis and treatment of NF-
PNETs may be slow because of its rarity[28]. Delayed diagnosis and treatment of PNETs 
are associated with more advanced tumor characteristics and higher recurrence 
rates[29]. The early diagnosis of PNETs is an important component of good prognoses 
for NF-PNET patients.
In this study, BMI and pathological tumor size in the Open and MIS groups differed 
for proximal pancreatic resections. The baseline characteristics of the groups may have 
differed because the resection approach was determined by tumor factors and 
surgeon’s preference. Other studies have suggested criteria for selecting a minimally 
invasive approach to treat left-sided pancreatic cancer[16,30]. The criteria used to select 
resected PNET patients may help improve the prognosis of the minimally invasive 
approach. In the current study, there was no difference in length of hospital stay 
between the minimally invasive approach group and the open resection group for 
proximal pancreatic resections. However, several studies have shown that a minimally 
invasive approach to pancreatic resection is strongly correlated with shorter hospital 
stays[6,7]. The fact that the current study showed no differences between groups may be 
a product of patient heterogeneity.
This study had several limitations. Despite its large sample size, it was based upon a 
Kim J et al. MIS vs open pancreatectomy for NFPNETs
WJGO https://www.wjgnet.com 1142 October 15, 2020 Volume 12 Issue 10
Figure 1  Changes in surgical approaches for treating nonfunctioning-pancreatic neuroendocrine tumors over time. MIS: Minimally invasive 
surgery.
Figure 2  Comparison of disease-free survival rates between open pancreatic resection and minimally invasive approaches for treating 
patients with nonfunctioning pancreatic neuroendocrine tumors. DFS: Disease-free survival; MIS: Minimally invasive surgery; NF-PNET: 
Nonfunctioning-pancreatic neuroendocrine tumors.
retrospective review of patient data and analyzed patients from a single center. Most 
of the patients who underwent a minimally invasive approach were diagnosed after 
2007, so they had shorter follow-up durations than the open pancreatic resection 
group. As the skills of pancreatic surgeons improve in using a minimally invasive 
approach, surgical duration, intra-operative bleeding amount, post-operative 
complication rates, conversion rates, and long-term outcomes are expected to differ 
over time. Surgeons chose whether to apply a minimally invasive approach, and 
subgroup analysis showed that the open pancreatic resection group had more 
advanced tumor features and a higher BMI than the MIS group. In the current study, 
minimally invasive approaches included laparoscopic and robotic approaches, so 
future studies should compare these approaches for the treatment of PNET patients.
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CONCLUSION
The proportion of minimally invasive approaches for the treatment of NF-PET has 
increased to more than 75%. There were no significant differences in the short- and 
long-term outcomes between open resection and minimally invasive distal 
pancreatectomy for the treatment of NF-PNET patients. Minimally invasive 
approaches including pylorus-preserving pancreaticoduodenectomies, central 
pancreatectomies, and total pancreatectomies had comparable post-operative 
complication rates and short-term outcomes. Regardless of the type of surgery, a 




The mainstay of treatment for nonfunctioning (NF)-pancreatic neuroendocrine tumors 
(PNETs) is surgical resection. Minimally invasive approaches to pancreatic resection 
are not yet widely accepted as NF-PNET treatment.
Research motivation
Some studies have shown laparoscopic distal pancreatectomy of NF-PNETs as 
producing post-operative complications and oncological outcomes that are 
comparable to the open approach. However, the long-term oncological outcomes of 
minimally invasive approaches to pancreaticoduodenectomies and other types of 
surgery for treating NF-PNETs remain unknown.
Research objectives
The current study was designed to determine the short- and long-term outcomes of 
minimally invasive pancreas resection conducted on patients with NF-PNETs.
Research methods
Severance Hospital’s prospective databases were searched for patients who underwent 
curative resections for NF-PNETs between January 2003 and August 2018. Patients 
who underwent pancreatectomy in combination with resection were excluded.
Research results
Groups of patients who underwent proximal pancreas resections (central 
pancreatectomies, pancreaticoduodenectomies, and total pancreatectomies), open 
resection, and minimally invasive resection showed similar levels of post-operative 
complications. The groups showed no difference between the rates of post-operative 
pancreatic fistulae. However, PNET patients showed high risk of forming post-
operative pancreatic fistulae, due to the softness of the pancreas and small diameter of 
its ducts. Large tumor size, poor differentiation, and lympho-vascular invasion were 
associated with NF-PNET tumor recurrence.
Research conclusions
Minimally invasive approaches of pylorus-preserving pancreaticoduodenectomy, 
central pancreatectomy, and total pancreatectomy led to comparable post-operative 
complication rates and short-term outcomes. The type of surgical approach (minimally 
invasive vs open) was not an independent prognostic factor in treating NF-PNET 
patients [Exp(β) = 1.062, P = 0.929]. Regardless of the type of surgery, a minimally 
invasive approach could be safe and feasible for select NF-PNETs patients who are 
undergoing pancreas resection.
Research perspectives
The current study of minimally invasive pancreatic surgeries collectively evaluated 
laparoscopic and robotic approaches. Future studies should involve comparison of the 
two ¾ laparoscopic vs robotic ¾ in treating PNET patients. Furthermore, use of the 
latest criteria to select resected PNET patients may help improve prognosis of the 
minimally invasive approach.
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